Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma

BACKGROUND: Over the last two decades it has become clear that distinct types of human papillomavirus (HPV), the so-called high-risk types (hrHPV), are the major cause of cervical cancer. The hrHPV-DNA testing has shown excellent performance in several clinical applications from screening to the fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Silvano, Venturoli, Simona, Origoni, Massimo, Preti, Mario, Mariani, Luciano, Cristoforoni, Paolo, Sandri, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431402/
https://www.ncbi.nlm.nih.gov/pubmed/25987897
http://dx.doi.org/10.3332/ecancer.2015.528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431402/
https://www.ncbi.nlm.nih.gov/pubmed/25987897
http://dx.doi.org/10.3332/ecancer.2015.528

Ejemplares similares